开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2148659, encodeId=cae92148659c2, content=偏重的研究方向：临床 经验分享：只接受约稿，不需稿费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230724/f6ff49274b4c450bb5ce22714896fd31/ef43ceb74c4f403797e71c4c086060e6.jpg, createdBy=33518647109, createdName=病理, createdTime=Tue Jul 18 20:11:26 CST 2023, time=2023-07-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1092103, encodeId=b2301092103b2, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493558, encodeId=56bf49355893, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑还是挺宽容，投稿一个月，回信说minor revision，3天后改好投回去，4天后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jan 21 10:21:00 CST 2013, time=2013-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508145, encodeId=a1975081459d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=093352426, createdName=zhoushukui, createdTime=Thu Dec 04 15:15:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092104, encodeId=69b51092104eb, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905817, encodeId=eca890581e42, content=还有没有人投这个杂志啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84a45111794, createdName=146185ebm42暂无昵称, createdTime=Mon Dec 07 22:06:42 CST 2020, time=2020-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578592, encodeId=2bd75e8592c8, content=命中率低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567792, encodeId=55c856e79274, content=没有159****8063 2019-01-25 发表:: 请问，该杂志有向你要CV了吗？？159****8063 2019-01-25 00:00:00 发表: 请问，该杂志有向你要CV了吗？？, beContent=159****8063 2019-01-25 发表:: 请问，该杂志有向你要CV了吗？？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/09/4253205594bd71c4f3c203938afa5a49.jpg, createdBy=fb3e2303729, createdName=暂2210e01m, createdTime=Fri Mar 08 00:00:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529141, encodeId=4ee85291419b, content=请问现在收版面费吗zhoushukui 2014-12-04 发表:: 研究方向：前列腺癌;; 接收率：约25% 审稿时间：约3个月投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, beContent=zhoushukui 2014-12-04 发表:: 研究方向：前列腺癌;; 接收率：约25% 审稿时间：约3个月投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=537, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadc1924494, createdName=小巫, createdTime=Tue Nov 08 23:05:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501504, encodeId=171e5015049d, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：临床基础均可，一篇meta文章投上去，经过under review 2月，最后被拒，真是悲剧啊。而且没有任何退稿意见，发信去询问，居然用日文回复，简直是。。。。以后再也不投这个杂志了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=553, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61154144, createdName=cweimed, createdTime=Sun Mar 02 14:04:00 CST 2014, time=2014-03-02, status=1, ipAttribution=)]

2023-07-18 病理来自安徽省

偏重的研究方向：临床
经验分享：只接受约稿，不需稿费

116 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2148659, encodeId=cae92148659c2, content=偏重的研究方向：临床 经验分享：只接受约稿，不需稿费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230724/f6ff49274b4c450bb5ce22714896fd31/ef43ceb74c4f403797e71c4c086060e6.jpg, createdBy=33518647109, createdName=病理, createdTime=Tue Jul 18 20:11:26 CST 2023, time=2023-07-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1092103, encodeId=b2301092103b2, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493558, encodeId=56bf49355893, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑还是挺宽容，投稿一个月，回信说minor revision，3天后改好投回去，4天后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jan 21 10:21:00 CST 2013, time=2013-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508145, encodeId=a1975081459d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=093352426, createdName=zhoushukui, createdTime=Thu Dec 04 15:15:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092104, encodeId=69b51092104eb, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905817, encodeId=eca890581e42, content=还有没有人投这个杂志啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84a45111794, createdName=146185ebm42暂无昵称, createdTime=Mon Dec 07 22:06:42 CST 2020, time=2020-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578592, encodeId=2bd75e8592c8, content=命中率低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567792, encodeId=55c856e79274, content=没有159****8063 2019-01-25 发表:: 请问，该杂志有向你要CV了吗？？159****8063 2019-01-25 00:00:00 发表: 请问，该杂志有向你要CV了吗？？, beContent=159****8063 2019-01-25 发表:: 请问，该杂志有向你要CV了吗？？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/09/4253205594bd71c4f3c203938afa5a49.jpg, createdBy=fb3e2303729, createdName=暂2210e01m, createdTime=Fri Mar 08 00:00:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529141, encodeId=4ee85291419b, content=请问现在收版面费吗zhoushukui 2014-12-04 发表:: 研究方向：前列腺癌;; 接收率：约25% 审稿时间：约3个月投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, beContent=zhoushukui 2014-12-04 发表:: 研究方向：前列腺癌;; 接收率：约25% 审稿时间：约3个月投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=537, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadc1924494, createdName=小巫, createdTime=Tue Nov 08 23:05:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501504, encodeId=171e5015049d, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：临床基础均可，一篇meta文章投上去，经过under review 2月，最后被拒，真是悲剧啊。而且没有任何退稿意见，发信去询问，居然用日文回复，简直是。。。。以后再也不投这个杂志了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=553, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61154144, createdName=cweimed, createdTime=Sun Mar 02 14:04:00 CST 2014, time=2014-03-02, status=1, ipAttribution=)]

2021-12-29 Gym璨烨

期刊给我发了一封信，但我看不懂怎么办？

150 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2148659, encodeId=cae92148659c2, content=偏重的研究方向：临床 经验分享：只接受约稿，不需稿费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230724/f6ff49274b4c450bb5ce22714896fd31/ef43ceb74c4f403797e71c4c086060e6.jpg, createdBy=33518647109, createdName=病理, createdTime=Tue Jul 18 20:11:26 CST 2023, time=2023-07-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1092103, encodeId=b2301092103b2, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493558, encodeId=56bf49355893, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑还是挺宽容，投稿一个月，回信说minor revision，3天后改好投回去，4天后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jan 21 10:21:00 CST 2013, time=2013-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508145, encodeId=a1975081459d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=093352426, createdName=zhoushukui, createdTime=Thu Dec 04 15:15:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092104, encodeId=69b51092104eb, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905817, encodeId=eca890581e42, content=还有没有人投这个杂志啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84a45111794, createdName=146185ebm42暂无昵称, createdTime=Mon Dec 07 22:06:42 CST 2020, time=2020-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578592, encodeId=2bd75e8592c8, content=命中率低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567792, encodeId=55c856e79274, content=没有159****8063 2019-01-25 发表:: 请问，该杂志有向你要CV了吗？？159****8063 2019-01-25 00:00:00 发表: 请问，该杂志有向你要CV了吗？？, beContent=159****8063 2019-01-25 发表:: 请问，该杂志有向你要CV了吗？？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/09/4253205594bd71c4f3c203938afa5a49.jpg, createdBy=fb3e2303729, createdName=暂2210e01m, createdTime=Fri Mar 08 00:00:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529141, encodeId=4ee85291419b, content=请问现在收版面费吗zhoushukui 2014-12-04 发表:: 研究方向：前列腺癌;; 接收率：约25% 审稿时间：约3个月投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, beContent=zhoushukui 2014-12-04 发表:: 研究方向：前列腺癌;; 接收率：约25% 审稿时间：约3个月投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=537, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadc1924494, createdName=小巫, createdTime=Tue Nov 08 23:05:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501504, encodeId=171e5015049d, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：临床基础均可，一篇meta文章投上去，经过under review 2月，最后被拒，真是悲剧啊。而且没有任何退稿意见，发信去询问，居然用日文回复，简直是。。。。以后再也不投这个杂志了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=553, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61154144, createdName=cweimed, createdTime=Sun Mar 02 14:04:00 CST 2014, time=2014-03-02, status=1, ipAttribution=)]

2013-01-21 匿名用户

审稿速度:2.0 | 投稿命中率:50.0
经验分享：编辑还是挺宽容，投稿一个月，回信说minor revision，3天后改好投回去，4天后就接收了。

522 0

[GetPortalCommentsPageByObjectIdResponse(id=2148659, encodeId=cae92148659c2, content=偏重的研究方向：临床 经验分享：只接受约稿，不需稿费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230724/f6ff49274b4c450bb5ce22714896fd31/ef43ceb74c4f403797e71c4c086060e6.jpg, createdBy=33518647109, createdName=病理, createdTime=Tue Jul 18 20:11:26 CST 2023, time=2023-07-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1092103, encodeId=b2301092103b2, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493558, encodeId=56bf49355893, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑还是挺宽容，投稿一个月，回信说minor revision，3天后改好投回去，4天后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jan 21 10:21:00 CST 2013, time=2013-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508145, encodeId=a1975081459d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=093352426, createdName=zhoushukui, createdTime=Thu Dec 04 15:15:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092104, encodeId=69b51092104eb, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905817, encodeId=eca890581e42, content=还有没有人投这个杂志啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84a45111794, createdName=146185ebm42暂无昵称, createdTime=Mon Dec 07 22:06:42 CST 2020, time=2020-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578592, encodeId=2bd75e8592c8, content=命中率低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567792, encodeId=55c856e79274, content=没有159****8063 2019-01-25 发表:: 请问，该杂志有向你要CV了吗？？159****8063 2019-01-25 00:00:00 发表: 请问，该杂志有向你要CV了吗？？, beContent=159****8063 2019-01-25 发表:: 请问，该杂志有向你要CV了吗？？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/09/4253205594bd71c4f3c203938afa5a49.jpg, createdBy=fb3e2303729, createdName=暂2210e01m, createdTime=Fri Mar 08 00:00:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529141, encodeId=4ee85291419b, content=请问现在收版面费吗zhoushukui 2014-12-04 发表:: 研究方向：前列腺癌;; 接收率：约25% 审稿时间：约3个月投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, beContent=zhoushukui 2014-12-04 发表:: 研究方向：前列腺癌;; 接收率：约25% 审稿时间：约3个月投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=537, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadc1924494, createdName=小巫, createdTime=Tue Nov 08 23:05:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501504, encodeId=171e5015049d, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：临床基础均可，一篇meta文章投上去，经过under review 2月，最后被拒，真是悲剧啊。而且没有任何退稿意见，发信去询问，居然用日文回复，简直是。。。。以后再也不投这个杂志了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=553, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61154144, createdName=cweimed, createdTime=Sun Mar 02 14:04:00 CST 2014, time=2014-03-02, status=1, ipAttribution=)]

2014-12-04 zhoushukui

审稿速度:3.0 | 投稿命中率:25.0
经验分享：投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了

500 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2148659, encodeId=cae92148659c2, content=偏重的研究方向：临床 经验分享：只接受约稿，不需稿费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230724/f6ff49274b4c450bb5ce22714896fd31/ef43ceb74c4f403797e71c4c086060e6.jpg, createdBy=33518647109, createdName=病理, createdTime=Tue Jul 18 20:11:26 CST 2023, time=2023-07-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1092103, encodeId=b2301092103b2, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493558, encodeId=56bf49355893, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑还是挺宽容，投稿一个月，回信说minor revision，3天后改好投回去，4天后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jan 21 10:21:00 CST 2013, time=2013-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508145, encodeId=a1975081459d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=093352426, createdName=zhoushukui, createdTime=Thu Dec 04 15:15:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092104, encodeId=69b51092104eb, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905817, encodeId=eca890581e42, content=还有没有人投这个杂志啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84a45111794, createdName=146185ebm42暂无昵称, createdTime=Mon Dec 07 22:06:42 CST 2020, time=2020-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578592, encodeId=2bd75e8592c8, content=命中率低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567792, encodeId=55c856e79274, content=没有159****8063 2019-01-25 发表:: 请问，该杂志有向你要CV了吗？？159****8063 2019-01-25 00:00:00 发表: 请问，该杂志有向你要CV了吗？？, beContent=159****8063 2019-01-25 发表:: 请问，该杂志有向你要CV了吗？？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/09/4253205594bd71c4f3c203938afa5a49.jpg, createdBy=fb3e2303729, createdName=暂2210e01m, createdTime=Fri Mar 08 00:00:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529141, encodeId=4ee85291419b, content=请问现在收版面费吗zhoushukui 2014-12-04 发表:: 研究方向：前列腺癌;; 接收率：约25% 审稿时间：约3个月投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, beContent=zhoushukui 2014-12-04 发表:: 研究方向：前列腺癌;; 接收率：约25% 审稿时间：约3个月投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=537, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadc1924494, createdName=小巫, createdTime=Tue Nov 08 23:05:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501504, encodeId=171e5015049d, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：临床基础均可，一篇meta文章投上去，经过under review 2月，最后被拒，真是悲剧啊。而且没有任何退稿意见，发信去询问，居然用日文回复，简直是。。。。以后再也不投这个杂志了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=553, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61154144, createdName=cweimed, createdTime=Sun Mar 02 14:04:00 CST 2014, time=2014-03-02, status=1, ipAttribution=)]

2021-12-27 msSSSSSD

期刊发送邮件中包括哪几个方面的内容？

144 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2148659, encodeId=cae92148659c2, content=偏重的研究方向：临床 经验分享：只接受约稿，不需稿费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230724/f6ff49274b4c450bb5ce22714896fd31/ef43ceb74c4f403797e71c4c086060e6.jpg, createdBy=33518647109, createdName=病理, createdTime=Tue Jul 18 20:11:26 CST 2023, time=2023-07-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1092103, encodeId=b2301092103b2, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493558, encodeId=56bf49355893, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑还是挺宽容，投稿一个月，回信说minor revision，3天后改好投回去，4天后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jan 21 10:21:00 CST 2013, time=2013-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508145, encodeId=a1975081459d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=093352426, createdName=zhoushukui, createdTime=Thu Dec 04 15:15:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092104, encodeId=69b51092104eb, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905817, encodeId=eca890581e42, content=还有没有人投这个杂志啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84a45111794, createdName=146185ebm42暂无昵称, createdTime=Mon Dec 07 22:06:42 CST 2020, time=2020-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578592, encodeId=2bd75e8592c8, content=命中率低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567792, encodeId=55c856e79274, content=没有159****8063 2019-01-25 发表:: 请问，该杂志有向你要CV了吗？？159****8063 2019-01-25 00:00:00 发表: 请问，该杂志有向你要CV了吗？？, beContent=159****8063 2019-01-25 发表:: 请问，该杂志有向你要CV了吗？？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/09/4253205594bd71c4f3c203938afa5a49.jpg, createdBy=fb3e2303729, createdName=暂2210e01m, createdTime=Fri Mar 08 00:00:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529141, encodeId=4ee85291419b, content=请问现在收版面费吗zhoushukui 2014-12-04 发表:: 研究方向：前列腺癌;; 接收率：约25% 审稿时间：约3个月投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, beContent=zhoushukui 2014-12-04 发表:: 研究方向：前列腺癌;; 接收率：约25% 审稿时间：约3个月投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=537, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadc1924494, createdName=小巫, createdTime=Tue Nov 08 23:05:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501504, encodeId=171e5015049d, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：临床基础均可，一篇meta文章投上去，经过under review 2月，最后被拒，真是悲剧啊。而且没有任何退稿意见，发信去询问，居然用日文回复，简直是。。。。以后再也不投这个杂志了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=553, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61154144, createdName=cweimed, createdTime=Sun Mar 02 14:04:00 CST 2014, time=2014-03-02, status=1, ipAttribution=)]

2020-12-07 146185ebm42暂无昵称

还有没有人投这个杂志啊

274 0

[GetPortalCommentsPageByObjectIdResponse(id=2148659, encodeId=cae92148659c2, content=偏重的研究方向：临床 经验分享：只接受约稿，不需稿费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230724/f6ff49274b4c450bb5ce22714896fd31/ef43ceb74c4f403797e71c4c086060e6.jpg, createdBy=33518647109, createdName=病理, createdTime=Tue Jul 18 20:11:26 CST 2023, time=2023-07-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1092103, encodeId=b2301092103b2, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493558, encodeId=56bf49355893, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑还是挺宽容，投稿一个月，回信说minor revision，3天后改好投回去，4天后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jan 21 10:21:00 CST 2013, time=2013-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508145, encodeId=a1975081459d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=093352426, createdName=zhoushukui, createdTime=Thu Dec 04 15:15:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092104, encodeId=69b51092104eb, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905817, encodeId=eca890581e42, content=还有没有人投这个杂志啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84a45111794, createdName=146185ebm42暂无昵称, createdTime=Mon Dec 07 22:06:42 CST 2020, time=2020-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578592, encodeId=2bd75e8592c8, content=命中率低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567792, encodeId=55c856e79274, content=没有159****8063 2019-01-25 发表:: 请问，该杂志有向你要CV了吗？？159****8063 2019-01-25 00:00:00 发表: 请问，该杂志有向你要CV了吗？？, beContent=159****8063 2019-01-25 发表:: 请问，该杂志有向你要CV了吗？？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/09/4253205594bd71c4f3c203938afa5a49.jpg, createdBy=fb3e2303729, createdName=暂2210e01m, createdTime=Fri Mar 08 00:00:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529141, encodeId=4ee85291419b, content=请问现在收版面费吗zhoushukui 2014-12-04 发表:: 研究方向：前列腺癌;; 接收率：约25% 审稿时间：约3个月投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, beContent=zhoushukui 2014-12-04 发表:: 研究方向：前列腺癌;; 接收率：约25% 审稿时间：约3个月投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=537, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadc1924494, createdName=小巫, createdTime=Tue Nov 08 23:05:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501504, encodeId=171e5015049d, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：临床基础均可，一篇meta文章投上去，经过under review 2月，最后被拒，真是悲剧啊。而且没有任何退稿意见，发信去询问，居然用日文回复，简直是。。。。以后再也不投这个杂志了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=553, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61154144, createdName=cweimed, createdTime=Sun Mar 02 14:04:00 CST 2014, time=2014-03-02, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

命中率低

261 0

[GetPortalCommentsPageByObjectIdResponse(id=2148659, encodeId=cae92148659c2, content=偏重的研究方向：临床 经验分享：只接受约稿，不需稿费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230724/f6ff49274b4c450bb5ce22714896fd31/ef43ceb74c4f403797e71c4c086060e6.jpg, createdBy=33518647109, createdName=病理, createdTime=Tue Jul 18 20:11:26 CST 2023, time=2023-07-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1092103, encodeId=b2301092103b2, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493558, encodeId=56bf49355893, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑还是挺宽容，投稿一个月，回信说minor revision，3天后改好投回去，4天后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jan 21 10:21:00 CST 2013, time=2013-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508145, encodeId=a1975081459d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=093352426, createdName=zhoushukui, createdTime=Thu Dec 04 15:15:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092104, encodeId=69b51092104eb, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905817, encodeId=eca890581e42, content=还有没有人投这个杂志啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84a45111794, createdName=146185ebm42暂无昵称, createdTime=Mon Dec 07 22:06:42 CST 2020, time=2020-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578592, encodeId=2bd75e8592c8, content=命中率低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567792, encodeId=55c856e79274, content=没有159****8063 2019-01-25 发表:: 请问，该杂志有向你要CV了吗？？159****8063 2019-01-25 00:00:00 发表: 请问，该杂志有向你要CV了吗？？, beContent=159****8063 2019-01-25 发表:: 请问，该杂志有向你要CV了吗？？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/09/4253205594bd71c4f3c203938afa5a49.jpg, createdBy=fb3e2303729, createdName=暂2210e01m, createdTime=Fri Mar 08 00:00:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529141, encodeId=4ee85291419b, content=请问现在收版面费吗zhoushukui 2014-12-04 发表:: 研究方向：前列腺癌;; 接收率：约25% 审稿时间：约3个月投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, beContent=zhoushukui 2014-12-04 发表:: 研究方向：前列腺癌;; 接收率：约25% 审稿时间：约3个月投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=537, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadc1924494, createdName=小巫, createdTime=Tue Nov 08 23:05:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501504, encodeId=171e5015049d, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：临床基础均可，一篇meta文章投上去，经过under review 2月，最后被拒，真是悲剧啊。而且没有任何退稿意见，发信去询问，居然用日文回复，简直是。。。。以后再也不投这个杂志了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=553, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61154144, createdName=cweimed, createdTime=Sun Mar 02 14:04:00 CST 2014, time=2014-03-02, status=1, ipAttribution=)]

2019-03-08 暂2210e01m

没有159****8063 2019-01-25 发表::
请问，该杂志有向你要CV了吗？？159****8063 2019-01-25 00:00:00 发表:
请问，该杂志有向你要CV了吗？？

159****8063 2019-01-25 发表:: 请问，该杂志有向你要CV了吗？？

283 0

[GetPortalCommentsPageByObjectIdResponse(id=2148659, encodeId=cae92148659c2, content=偏重的研究方向：临床 经验分享：只接受约稿，不需稿费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230724/f6ff49274b4c450bb5ce22714896fd31/ef43ceb74c4f403797e71c4c086060e6.jpg, createdBy=33518647109, createdName=病理, createdTime=Tue Jul 18 20:11:26 CST 2023, time=2023-07-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1092103, encodeId=b2301092103b2, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493558, encodeId=56bf49355893, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑还是挺宽容，投稿一个月，回信说minor revision，3天后改好投回去，4天后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jan 21 10:21:00 CST 2013, time=2013-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508145, encodeId=a1975081459d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=093352426, createdName=zhoushukui, createdTime=Thu Dec 04 15:15:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092104, encodeId=69b51092104eb, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905817, encodeId=eca890581e42, content=还有没有人投这个杂志啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84a45111794, createdName=146185ebm42暂无昵称, createdTime=Mon Dec 07 22:06:42 CST 2020, time=2020-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578592, encodeId=2bd75e8592c8, content=命中率低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567792, encodeId=55c856e79274, content=没有159****8063 2019-01-25 发表:: 请问，该杂志有向你要CV了吗？？159****8063 2019-01-25 00:00:00 发表: 请问，该杂志有向你要CV了吗？？, beContent=159****8063 2019-01-25 发表:: 请问，该杂志有向你要CV了吗？？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/09/4253205594bd71c4f3c203938afa5a49.jpg, createdBy=fb3e2303729, createdName=暂2210e01m, createdTime=Fri Mar 08 00:00:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529141, encodeId=4ee85291419b, content=请问现在收版面费吗zhoushukui 2014-12-04 发表:: 研究方向：前列腺癌;; 接收率：约25% 审稿时间：约3个月投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, beContent=zhoushukui 2014-12-04 发表:: 研究方向：前列腺癌;; 接收率：约25% 审稿时间：约3个月投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=537, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadc1924494, createdName=小巫, createdTime=Tue Nov 08 23:05:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501504, encodeId=171e5015049d, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：临床基础均可，一篇meta文章投上去，经过under review 2月，最后被拒，真是悲剧啊。而且没有任何退稿意见，发信去询问，居然用日文回复，简直是。。。。以后再也不投这个杂志了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=553, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61154144, createdName=cweimed, createdTime=Sun Mar 02 14:04:00 CST 2014, time=2014-03-02, status=1, ipAttribution=)]

2016-11-08 小巫

请问现在收版面费吗zhoushukui 2014-12-04 发表::
研究方向：前列腺癌;; 接收率：约25% 审稿时间：约3个月投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了

zhoushukui 2014-12-04 发表:: 研究方向：前列腺癌;; 接收率：约25% 审稿时间：约3个月投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了

537 0

[GetPortalCommentsPageByObjectIdResponse(id=2148659, encodeId=cae92148659c2, content=偏重的研究方向：临床 经验分享：只接受约稿，不需稿费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230724/f6ff49274b4c450bb5ce22714896fd31/ef43ceb74c4f403797e71c4c086060e6.jpg, createdBy=33518647109, createdName=病理, createdTime=Tue Jul 18 20:11:26 CST 2023, time=2023-07-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1092103, encodeId=b2301092103b2, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493558, encodeId=56bf49355893, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑还是挺宽容，投稿一个月，回信说minor revision，3天后改好投回去，4天后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jan 21 10:21:00 CST 2013, time=2013-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508145, encodeId=a1975081459d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=093352426, createdName=zhoushukui, createdTime=Thu Dec 04 15:15:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092104, encodeId=69b51092104eb, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905817, encodeId=eca890581e42, content=还有没有人投这个杂志啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84a45111794, createdName=146185ebm42暂无昵称, createdTime=Mon Dec 07 22:06:42 CST 2020, time=2020-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578592, encodeId=2bd75e8592c8, content=命中率低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567792, encodeId=55c856e79274, content=没有159****8063 2019-01-25 发表:: 请问，该杂志有向你要CV了吗？？159****8063 2019-01-25 00:00:00 发表: 请问，该杂志有向你要CV了吗？？, beContent=159****8063 2019-01-25 发表:: 请问，该杂志有向你要CV了吗？？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/09/4253205594bd71c4f3c203938afa5a49.jpg, createdBy=fb3e2303729, createdName=暂2210e01m, createdTime=Fri Mar 08 00:00:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529141, encodeId=4ee85291419b, content=请问现在收版面费吗zhoushukui 2014-12-04 发表:: 研究方向：前列腺癌;; 接收率：约25% 审稿时间：约3个月投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, beContent=zhoushukui 2014-12-04 发表:: 研究方向：前列腺癌;; 接收率：约25% 审稿时间：约3个月投稿系统设计的比较好，半个小时完成投稿，具体中没中看运气了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=537, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadc1924494, createdName=小巫, createdTime=Tue Nov 08 23:05:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501504, encodeId=171e5015049d, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：临床基础均可，一篇meta文章投上去，经过under review 2月，最后被拒，真是悲剧啊。而且没有任何退稿意见，发信去询问，居然用日文回复，简直是。。。。以后再也不投这个杂志了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=553, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61154144, createdName=cweimed, createdTime=Sun Mar 02 14:04:00 CST 2014, time=2014-03-02, status=1, ipAttribution=)]

2014-03-02 cweimed

审稿速度:2.0 | 投稿命中率:50.0
经验分享：临床基础均可，一篇meta文章投上去，经过under review 2月，最后被拒，真是悲剧啊。而且没有任何退稿意见，发信去询问，居然用日文回复，简直是。。。。以后再也不投这个杂志了。

553 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务